Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.6T | 19.8T | 17.6T | 16.4T |
Cost of revenue | 7.5T | 9.4T | 8.4T | 8.9T |
Gross profit | 10.1T | 10.4T | 9.2T | 7.5T |
Operating expense | ||||
Research & development | — | 1.3T | 1.1T | 1.1T |
Selling general and admin | 2.7T | 496.5B | 430.4B | 406.9B |
Other operating expenses | — | 28.1B | 27.2B | 25.6B |
Operating income | 10.1T | 8.1T | 7.0T | 5.5T |
Non operating interest income | ||||
Income | — | 98.4B | 81.8B | 84.4B |
Expense | — | 268.5B | 315.0B | 359.5B |
Other income expense | — | — | — | — |
Pretax income | 9.3T | 9.6T | 6.9T | 5.1T |
Tax provision | 1.2T | 1.6T | 1.1T | 932.2B |
Net income | 8.1T | 8.0T | 5.8T | 4.1T |
Basic EPS | 11.7K | — | 8.3K | 6.0K |
Diluted EPS | 11.7K | — | 7.9K | 5.9K |
Basic average shares | — | — | 689.0M | 688.7M |
Diluted average shares | — | — | 725.5M | 693.9M |
EBITDA | 10.1T | 12.1T | 10.3T | 8.6T |
Net income from continuing op. | — | 8.0T | 5.8T | 4.1T |
Minority interests | -1.1B | -6.0B | -4.7B | 276M |
Preferred stock dividends | — | — | — | — |